Screening of PIP5K2A promoter region for mutations in bipolar disorder and schizophrenia

Psychiatric Genetics

Volumn 15, Issue 3, 2005, Pages 223-227

  Stopkova, Pavla ^a   Vevera, Jan ^b   Paclt, Ivo ^b   Zukov, Ilja ^b   Papolos, Demitri F ^a   Saito, Takuya ^a   Lachman, Herbert M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Bipolar disorder; Inositol phosphate; Lithium; Phosphatidylinositol; Schizophrenia

Indexed keywords

PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE 2ALPHA; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; UNCLASSIFIED DRUG;

ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CHROMOSOME 10P; CONTROLLED STUDY; DNA SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE FREQUENCY; GENE MUTATION; GENETIC LINKAGE; GENETIC SCREENING; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SINGLE STRAND CONFORMATION POLYMORPHISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BASE SEQUENCE; BIPOLAR DISORDER; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); SCHIZOPHRENIA;

EID: 24144453618     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200509000-00015     Document Type: Article

References (40)

1. Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JI Jr, et al. (1994). Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci USA 91:5918-5921.
2. Berridge MJ, Irvine RF (1989). Inositol phosphates and cell signaling. Nature 341:197-205.
3. Brzustowicz LM, Hodgkinson K, Chow EW, Honer WG, Bassett AS (2000). Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288:678-682.
4. Cremona O, De Camilli P (2001). Phosphoinositides in membrane traffic at the synapse. J Cell Sci 114 (Pt 6):1041-1052 (review).
5. Detera-Wadleigh SD, Badner JA, Yoshikawa T, Sanders AR, Goldin LR, Turner G, et al. (1997). Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am J Med Genet (Neuropsychiatr Genet) 74:254-262.
6. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G, et al. (1999). A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 96:5604-5609.
7. Eberhard DA, Cooper CL, Low MG, Holz RW (1990). Evidence that the inositol phospholipids are necessary for exocytosis. Loss of inositol phospholipids and inhibition of secretion in permeabilized cells caused by a bacterial phospholipase C and removal of ATP. Biochem J 268:15-25.
8. Ekelund J, Hovatta I, Parker A, Paunio T, Varilo T, Martin R, et al. (2001). Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet 10:1611-1617
9. Escamillia MA, McInnes LA, Service SK, Spesny M, Reus VI, Gallegos A, et al. (2001). Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18. Am J Med Genet (Neuropsychiatr Genet) 105:207-213.
10. Ewald H, Mors O, Koed K, Eiberg H, Kruse TA (1997). Susceptibility loci for bipolar affective disorder on chromosome 18? A review and a study of Danish families. Psychiatr Genet 7:1-12 (review).
11. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, et al. (1998). Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet (Neuropsychiatr Genet) 81:290-295.
12. Faraone SV, Meyer J, Matise T, Svrakic D, Pepple J, Malaspina D, et al. (1999). Suggestive linkage of chromosome 10p to schizophrenia is not due to transmission ratio distortion. Am J Med Genet (Neuropsychiatr Genet) 88:607-608.
13. Foroud T, Castelluccio PF, Koller DL, Edenberg HJ, Miller M, Bowman E, et al. (2000). Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. Am J Med Genet (Neuropsychiatr Genet) 96:18-23.
14. Gehrmann T, Heilmeyer LM Jr, (1998). Phosphatidylinosital 4-Kinases. Eur J Biochem 253:357-370.
15. Hallcher L, Sherman WR (1980). The effects of lithium and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 261:8100-8130.
16. Hope BT, Kelz MB, Duman RS, Nestler EJ (1994). Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J Neurosci 14:4318-4328.
17. Jope RS, Bijur GN (2002). Mood stabilizers, glycogen synthase kinase-3beta and cell survival. Mol Psychiatry 7 (Suppl. 1):S35-S45.
18. Lachman HM, Kelsoe JR, Remick RA, Sadovnick AD, Rapaport MH, Lin M, et al. (1997). Linkage studies support a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22. Am J Med Genet (Neuropsychiatr Genet) 74:121-128.
19. Lenox RH, Wang L (2003). Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks. Mol Psychiatry 8: 135-144.
20. Levinson DF, Mahtani MM, Nancarrow DJ, Brown DM, Kruglyak L, Kirby A, et al. (1998). Genome scan of schizophrenia. Am J Psychiatry 155:741-750.
21. Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV, et al. (2000). Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet 67:652-663.
22. Manji HK, Moore GJ, Chen G (2001). Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. Br J Psychiatr 41:s107-s109.
23. Maziade M, Roy MA, Rouillard E, Bissonnette L, Fournier JP, Roy A, et al. (2001). A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes. Mol Psychiatry 6:684-693.
24. Mowry BJ, Ewen KR, Nancarrow DJ, Lennon DP, Nertney DA, Jones HL, et al. (2000). Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. Am J Med Genet (Neuropsychiatr Genet) 96:864-869
25. Nishizuka Y (1992). Intracellular signaling by hydrolysis of phospholipid and activation of protein kinase C. Science 258:607-614
26. Nurnberger JI, Foroud T (1999). Chromosome 6 workshop report. Am J Med Genet (Neuropsychiatr Genet) 88:233-238.
27. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989). Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770.
28. Rice JP, Goate A, Williams JT, Bierut L, Dorr D, Wu W, et al. (1997). Am J Med Genet (Neuropsychiatr Genet) 74:247-253.
29. Schwab SG, Hallmayer J, Albus M, Lerer B, Hnases C, Kanyas K, et al. (1998). Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet (Neuropsychiatr Genet) 81:302-307.
30. Schwab SG, Sklar P, Hallmayer J, Albus M, Rietschel M, Lerer B, et al. (2001). Association of SNPs with schizophrenia on chromosome 10p, a region with previously detected linkage. Am J Med Genet (Neuropsychiatr Genet) 105:562 (abstract).
31. Shaw SH, Kelly M, Smith AB, Shields G, Hopkins PJ, Loftus J, et al. (1998). A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet (Neuropsychiatr Genet) 81:364-376.
32. Spitzer RL, Endicott J, Robins E (1978). Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35:773-782
33. Stopkova P, Saito T, Fann CSJ, Papolos DF, Vevera J, Paclt I, et al. (2003). Polymorphism screening of PIP5K2A: a candidate gene for chromosome 10p-linked psychiatric disorders. Am J Med Genet (Neuropsychiatr Genet) 123B:50-58.
34. Stopkova P, Saito T, Papolos DF, Vevera J, Paclt I, Zukov I, et al. (2004). Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia. Biol Psychiatry 55:981-988.
35. Straub RE, Lehner T, Luo Y, Loth JE, Shao W, Sharpe L (1994). A possible vulnerability locus for BP affective disorder on chromosome 21. Nature Genet 8:291-296.
36. Straub RE, MacLean CJ, Myakishev MV, Harris-Kerr C, O'Neil FA, Walsh D, et al. (1998). A schizophrenia locus may be located in region 10p15.1. Am J Med Genet (Neuropsychiatr Genet) 81:296-301.
37. Tsuang DW, Skol AD, Faraone SV, Bingham S, Young KA, Prabhudesai S, et al. (2001). Examination of genetic linkage of chromosome 15 to schizophrenia in a large veterens affairs cooperative study sample. Am J Med Genet (Neuropsychiatr Genet) 105:662-668.
38. Wenk MR, Pellegrini L, Klenchin VA, Di Paolo G, Chang S, Daniell L, et al. (2001). PIP kinase I gamma is the major PI(5)P(2) synthesizing enzyme at the synapse. Neuron 32:79-88
39. Yoshikawa T, Kikuchi M, Saito K, Watanabe A, Yamada K, Shibuya H, et al. (2001). Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples. Mol Psychiatry 6:202-210.
40. Zhao FQ, Adachi K, Oka T (2002). Involvement of Oct-1 in transcriptional regulation beta-casein gene expression in mouse mammary gland. Biochim Biophys Acta 1577:27-37.